# Revelation Partners

> Revelation Partners provides growth capital and liquidity solutions to private healthcare companies, shareholders and funds. Nouscom named the firm as a co-lead of its October 19, 2026 Series D, disclosed as $135M equivalent to EUR120M. Individual allocations were not disclosed.

## Profile

- **Stage-based planning range:** $100K–$1M
- **Check-size evidence basis:** estimated
- **Founded:** N/A
- **Headquarters:** N/A
- **AUM:** N/A
- **Rounds they lead:** N/A
- **Rounds they invest:** N/A
- **Last verified:** 2026-10-19

## Links

- [Website](https://revelation-partners.com/)

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** October 19, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/fund/revelation-partners